A patient is being treated with sucralfate for gastroesophageal reflux disease. Which teaching point would the nurse emphasize?

Sucralfate is a locally acting medication that requires a specific sequence of administration to be effective. Its primary function is to bind to denuded mucosa and form a physical barrier. Because this barrier can trap other substances, it significantly impacts the pharmacokinetics of co-administered oral medications by preventing their contact with the absorptive surface. A. Contraindicated during pregnancy; women of childbearing age must use reliable contraception: This warning is specific to misoprostol, a prostaglandin analog used for ulcer prevention, which can induce labor. Sucralfate is generally considered safe during pregnancy because systemic absorption is negligible. It does not carry teratogenic risks. B. Avoid driving or operating heavy machinery until accustomed to sedating effects: Sucralfate does not cross the blood-brain barrier and has no effect on the central nervous system. It does not cause drowsiness or impaired coordination. This teaching point would be more appropriate for antihistamines or opioid analgesics. C. Oral anticoagulants, theophylline, and propranolol may require dosage reductions: Sucralfate decreases the absorption of these drugs, meaning their blood levels would likely fall rather than rise. Consequently, a dosage increase or better timing might be needed, not a reduction. The issue is decreased efficacy, not toxicity. D. Coating action may interfere with absorption of other drugs - separate by 2 hours: To prevent therapeutic failure, other medications should be administered at least 2 hours before or after sucralfate. The protective paste formed by the drug can sequester other molecules, preventing them from reaching the systemic circulation. Timing is critical for polypharmacy.